Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495300 · ClinicalTrials.gov registry record
Collection of Samples and Data for the National Marrow Donor Program Repository
A clinical trial of Bone Marrow Transplantation, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 395
- Enrollment target
- 1
- Study location
NCT00495300 is a study of Bone Marrow Transplantation that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 395 participants, above the 274-participant average among 5 other Bone Marrow Transplantation trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00495300, a study of Bone Marrow Transplantation, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 395 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol will collect blood samples and medical information from patients who have had a bone marrow transplant using cells from an unrelated donor identified through the National Marrow Donor Program (NMDP). The NMDP has two programs in which patients can participate: the Research Database Program and the Research Sample Repository. Patients who have received a bone marrow transplant at the NIH or other institution from an unrelated donor affiliated with the NMDP may be eligible for this study. Participants in the NMDP Research Database program will have medical information about their disease and their transplant sent to the NMDP before and after the transplant and once a year for the rest of their life. The information will be used to help determine how well transplant recipients recover from their transplant, how recovery after a transplant can be improved, how access to transplant for different groups of patients can be improved and how well donors recover from collection procedures. Participants in the NMDP Research Sample Repository program will have a small blood sample drawn from a vein in the arm just before they start taking medicines for the conditioning regimen to prepare them for the transplant. The blood samples will be used to look at ways to improve how patients are matched with their donors, to determine and evaluate the factors that affect transplant outcome, and to help develop methods to improve tissue matching between donors and recipients.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 395 participants |
| Start Date | 2007-08-31 |
| Est. Completion | 2024-08-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00495300
The ClinicalTrials.gov registry entry for NCT00495300 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 395 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 274-participant average among 5 other Bone Marrow Transplantation trials with a reported enrollment target (44% higher). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bone Marrow Transplantation appearing as the primary indexed condition, and to 0 interventions.
NCT00495300 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00495300 about?
NCT00495300 is a clinical study titled "Collection of Samples and Data for the National Marrow Donor Program Repository". This protocol will collect blood samples and medical information from patients who have had a bone marrow transplant using cells from an unrelated donor identified through the National Marrow Donor Program (NMDP). The NMDP has two programs in which patients can participate: the Research Database Pro...
What is the current status of trial NCT00495300?
This trial is currently completed. The enrollment target is 395 participants. The study started on 2007-08-31. Estimated completion is 2024-08-26.
What conditions does trial NCT00495300 study?
This clinical trial studies the following conditions: Bone Marrow Transplantation.
Who is sponsoring clinical trial NCT00495300?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00495300 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Marrow Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biomarkers in Transplant Recipients to Improve Outcomes
RECRUITING
-
Education Program to Manage Emotional Stress of Stem Cell Transplant Recipients and Their Caregivers
COMPLETED · Phase 1
-
An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers
COMPLETED · Phase 1
-
Valacyclovir in Immunocompromised Children
COMPLETED · Phase 1
-
Impact of Physical and Occupational Therapy in New BMT Patients
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.